Applied Lifesciences & Systems, LLC is a bio-systems company based in Raleigh, North Carolina, established in 2011. The company specializes in developing automated solutions for the detection, targeting, and delivery of vaccines in the poultry, aquaculture, and livestock sectors. Its innovative vaccine delivery system aims to enhance current vaccination methods by ensuring that each chick receives an accurate and consistent vaccination. This precision not only boosts the natural immune response to diseases but also improves overall flock health, contributing to cleaner and healthier poultry. Applied Lifesciences & Systems is committed to advancing animal health and productivity through its cutting-edge technology.
Private Equity Round in 2022
Silicon Ranch Corporation is a Nashville-based company that develops, owns, and operates utility-scale solar power projects. Founded in 2010, the company focuses on delivering reliable and cost-effective solar energy solutions to a variety of clients, including utilities, military installations, and commercial businesses. Silicon Ranch is committed to long-term ownership of its projects, ensuring accountability and support for its partners and the communities it serves. The company also operates a regional energy-training center that provides training in solar installation, maintenance, and weatherization, further contributing to local economic development and job creation. Notable projects include a solar array in Social Circle, Georgia, and a facility at Volkswagen's manufacturing site in Chattanooga, Tennessee.
Circular Genomics is a biotechnology company based in Albuquerque, New Mexico, focused on developing RNA-based diagnostic and therapeutic assays aimed at treating psychiatric and neurological diseases. Founded in 2021, the company specializes in circular RNA diagnostics, which provide an evidence-based approach to managing depressive disorders. This innovative technology significantly reduces the time required to achieve a therapeutic response in patients, allowing healthcare providers to more effectively diagnose and treat various psychiatric conditions. Through its advancements in RNA diagnostics, Circular Genomics seeks to enhance treatment outcomes for individuals suffering from these challenging illnesses.
Applied Lifesciences & Systems, LLC is a bio-systems company based in Raleigh, North Carolina, established in 2011. The company specializes in developing automated solutions for the detection, targeting, and delivery of vaccines in the poultry, aquaculture, and livestock sectors. Its innovative vaccine delivery system aims to enhance current vaccination methods by ensuring that each chick receives an accurate and consistent vaccination. This precision not only boosts the natural immune response to diseases but also improves overall flock health, contributing to cleaner and healthier poultry. Applied Lifesciences & Systems is committed to advancing animal health and productivity through its cutting-edge technology.
Mindera Health is a biotechnology company specializing in non-invasive molecular testing devices for skin cancer and other skin diseases. Founded in 2013 and based in Palo Alto, California, the company has developed innovative solutions such as a micro-needle array patch that allows for pain-free and targeted extraction of biomarkers, including RNA, DNA, and proteins, without the need for traditional skin biopsies. Mindera Health focuses on scalable technologies that facilitate the collection and evaluation of genetic data, enabling patients, healthcare professionals, and payers to make informed, data-driven decisions regarding treatment options. The company's advancements in biomarker identification and patient prediction analysis leverage deep learning to optimize treatment plans, particularly for conditions like psoriasis, where the technology helps identify patients best suited for specific biologic therapies.
Advanced Animal Diagnostics, Inc. commercializes proprietary technology for the diagnosis of farm-animal diseases. It uses an animal's own immune response to detect and stage infections to improve the quality of life for producers, processors, animals, and consumers. The company offers QuickSmear, a rapid differential slide to speed and simplify production animal research using differential cell counts; and SCC+ System for early detection of mastitis. Advanced Animal Diagnostics was founded in 2001 and is based in Durham, North Carolina.
Silicon Ranch Corporation is a Nashville-based company that develops, owns, and operates utility-scale solar power projects. Founded in 2010, the company focuses on delivering reliable and cost-effective solar energy solutions to a variety of clients, including utilities, military installations, and commercial businesses. Silicon Ranch is committed to long-term ownership of its projects, ensuring accountability and support for its partners and the communities it serves. The company also operates a regional energy-training center that provides training in solar installation, maintenance, and weatherization, further contributing to local economic development and job creation. Notable projects include a solar array in Social Circle, Georgia, and a facility at Volkswagen's manufacturing site in Chattanooga, Tennessee.
AN2 Therapeutics, Inc. is a biopharmaceutical company based in Menlo Park, California, dedicated to the research, development, and commercialization of innovative medicines for infectious diseases. Incorporated in 2017, the company is currently focused on its lead product candidate, epetraborole, a once-daily oral treatment aimed at addressing chronic non-tuberculous mycobacterial lung disease, a condition with significant unmet medical needs. AN2 Therapeutics is also involved in strategic partnerships, notably with Brii Biosciences, to enhance its development capabilities and reach. The company’s commitment is to leverage modern biomedical expertise to deliver transformational therapies for patients suffering from serious infections.
Applied Lifesciences & Systems, LLC is a bio-systems company based in Raleigh, North Carolina, established in 2011. The company specializes in developing automated solutions for the detection, targeting, and delivery of vaccines in the poultry, aquaculture, and livestock sectors. Its innovative vaccine delivery system aims to enhance current vaccination methods by ensuring that each chick receives an accurate and consistent vaccination. This precision not only boosts the natural immune response to diseases but also improves overall flock health, contributing to cleaner and healthier poultry. Applied Lifesciences & Systems is committed to advancing animal health and productivity through its cutting-edge technology.
PhaseBio Pharmaceuticals is a clinical-stage biopharmaceutical company based in Malvern, Pennsylvania, focused on developing innovative therapies for cardiopulmonary diseases. Its lead product candidate, PB2452, is a reversal agent for the antiplatelet drug ticagrelor and is currently undergoing Phase III clinical trials for patients experiencing uncontrolled bleeding or requiring urgent surgery. The company is also advancing PB1046, a fusion protein aimed at treating pulmonary arterial hypertension, which is in Phase IIb clinical trials. Additionally, PhaseBio is developing PB6440, an oral agent intended for the treatment of resistant hypertension. Founded in 2002, the company leverages proprietary recombinant biopolymers to enhance the stability and efficacy of its drug candidates.
ORIG3N, Inc. is a biotechnology company focused on developing innovative treatments for rare genetically inherited diseases, particularly affecting the heart, liver, and neurodegenerative conditions. Founded in 2014 and based in Boston, Massachusetts, ORIG3N utilizes induced pluripotent stem cell technology, enabling the differentiation of cells into any type found in the body. This technology serves multiple purposes, including drug efficacy testing, medication toxicity screening, and facilitating personalized treatment approaches. The company's product offerings include LifeProfiles, a suite of genetic tests such as FITCODE, which provides insights into fitness-related traits; the Run DNA test for optimizing running performance; AURA, which assesses skin health; and Life Capsule, a repository for blood cells aimed at regenerative medicine development.
Appello Pharmaceuticals, Inc. is a preclinical-stage company based in Nashville, Tennessee, specializing in the development of innovative positive allosteric modulators of mGlu4. These compounds are being investigated for their potential in treating Parkinson’s disease. The company aims to advance its research to provide new therapeutic options for this neurological disorder.
NeuroTronik
Series B in 2017
NeuroTronik, spun out of medical technology incubator Synecor, is developing a medical device that could take the place of drugs currently used to heart failure. Read more about the company's technology,
Boragen Inc. is a biotechnology company based in Durham, North Carolina, that specializes in designing and developing multifunctional small molecule boron solutions for applications in crop protection, animal health, and human health. Founded in 2015, the company focuses on creating next-generation fungicides through its synthetic chemistry platforms, which aim to promote sustainable farming practices. Boragen's product pipeline includes BAG8, a boron-based multisite fungicide, and BN2266, which targets mRNA processing as a crop protection fungicide. Additionally, the company is developing a dual-function nematicide-fungicide designed for root protection and endo-parasiticides that address resistance challenges. Through its innovative approach, Boragen seeks to enhance agricultural efficiency while minimizing chemical usage.
G1 Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of small molecule therapeutics for cancer treatment. Founded in 2008, the company is headquartered in Research Triangle Park, North Carolina. G1 Therapeutics is advancing several investigational therapies, including trilaciclib, an intravenous cyclin-dependent kinase (CDK) 4/6 inhibitor, currently undergoing Phase 1b/2 trials for extensive-stage small cell lung cancer and Phase 2 trials for first-line small cell lung cancer and metastatic triple-negative breast cancer. The company is also developing lerociclib, an oral CDK4/6 inhibitor, which is in Phase 1b/2a trials for breast cancer and Phase 1b trials for non-small cell lung cancer. Additionally, G1 Therapeutics is progressing rintodestrant, an oral selective estrogen receptor degrader, currently in Phase I/2 trials. The company has partnered with Quantum Leap Healthcare Collaborative to evaluate trilaciclib for neoadjuvant treatment in locally advanced breast cancer. G1 Therapeutics aims to improve treatment outcomes for cancer patients through its innovative therapeutic approaches.
ORIG3N, Inc. is a biotechnology company focused on developing innovative treatments for rare genetically inherited diseases, particularly affecting the heart, liver, and neurodegenerative conditions. Founded in 2014 and based in Boston, Massachusetts, ORIG3N utilizes induced pluripotent stem cell technology, enabling the differentiation of cells into any type found in the body. This technology serves multiple purposes, including drug efficacy testing, medication toxicity screening, and facilitating personalized treatment approaches. The company's product offerings include LifeProfiles, a suite of genetic tests such as FITCODE, which provides insights into fitness-related traits; the Run DNA test for optimizing running performance; AURA, which assesses skin health; and Life Capsule, a repository for blood cells aimed at regenerative medicine development.
splitsecnd offers a portable plug-in vehicle connectivity device that enhances driver safety and emergency response. The device plugs into the 12V lighter outlet of any car and utilizes airbag sensor technology to detect crashes. Upon impact, it automatically alerts emergency services, connects the user to a live operator, dispatches help to the location, and notifies designated emergency contacts. Additionally, the device can be manually activated in emergencies or roadside breakdowns. Beyond emergency response, splitsecnd features comprehensive trip analytics and GPS capabilities, allowing users to track routes, promote safe driving habits, and locate parked vehicles. This device is designed for a wide range of drivers, including seniors and teens, providing peace of mind without the need for a cell phone.
Restore Medical Solutions, Inc. is a medical device company based in Memphis, Tennessee, founded in 2012. The company specializes in manufacturing modular sterilization tray systems designed for use in hospitals and surgery centers. These systems aim to reduce the risk of surgical site infections by minimizing contamination from medical instruments. By enhancing efficiency and safety in healthcare settings, Restore Medical Solutions helps surgical departments improve the quality of care while also lowering costs. The innovative design of its products contributes to better operational productivity and supports the overall goal of delivering high-standard healthcare.
MedCenterDisplay, LLC specializes in digital patient satisfaction and engagement solutions for hospitals and clinics across the United States. Founded in 2007 and based in Brentwood, Tennessee, the company offers a comprehensive range of services, including digital signage, online marketing, and application development, aimed at enhancing patient engagement and satisfaction. Their innovative digital signage systems are designed to effectively communicate with patients and their families while they wait for medical services. Additionally, MedCenterDisplay provides online marketing solutions such as search engine optimization, reputation management, social media support, and website development. The company's services are tailored to improve healthcare outcomes, reduce avoidable readmissions, and enhance patient experience metrics like HCAHPS. MedCenterDisplay operates as a subsidiary of PatientPoint, LLC, further solidifying its role in the healthcare marketing landscape.
Myomo, Inc. is a medical technology company based in Cambridge, Massachusetts, specializing in wearable medical robotics. Founded in 2004, Myomo develops myoelectric orthotics, particularly the MyoPro, a myoelectric-controlled upper limb brace designed to assist individuals with neuromuscular disorders, including those resulting from strokes, spinal cord injuries, and other neurological conditions. The MyoPro supports weak or paralyzed arms, facilitating daily activities at home and in the community. The company also offers the mPower 1000, a lightweight functional arm brace that aids in restoring movement, as well as a suite of therapeutic programs, including the PERL technique and myGames, which leverage virtual reality to enhance rehabilitation. Myomo's products are distributed through orthotics and prosthetics providers, rehabilitation hospitals, and the Veterans Health Administration, serving medical professionals, patients, and caregivers across the United States.
NuSirt Sciences, Inc. is a biotechnology company based in Nashville, Tennessee, established in 2007. It focuses on developing innovative products for the prevention and treatment of metabolic diseases related to over-nutrition, such as obesity and type 2 diabetes. The company's technology platform combines natural compounds with pharmaceutical agents to activate sirtuin pathways, aiming to reduce the dosage of metformin, a standard treatment for early-stage type 2 diabetes, which some patients find difficult to tolerate due to side effects. NuSirt's lead product, NS-0100, combines leucine with a low dose of metformin and is currently undergoing Phase 2 clinical trials to determine its efficacy. The company has filed eleven patent applications, with two patents issued, and has conducted multiple pre-clinical and clinical studies to support its patented technologies. NuSirt has also formed strategic partnerships to enhance its research and development efforts in the field.
Contego Medical, Inc. develops emboli protection devices that are used for the treatment of cardiovascular and endovascular diseases. It offers angioplasty balloons and stent delivery catheters, such as coronary stent systems, carotid post-dilation balloons, and renal artery stent systems with integrated embolic protection devices for enabling carotid, renal, SVG, and coronary interventions. Contego Medical, Inc. was formerly known as Contego Medical, LLC. The company was founded in 2005 and is based in Raleigh, North Carolina with an additional office in Curitiba, Brazil.
G1 Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of small molecule therapeutics for cancer treatment. Founded in 2008, the company is headquartered in Research Triangle Park, North Carolina. G1 Therapeutics is advancing several investigational therapies, including trilaciclib, an intravenous cyclin-dependent kinase (CDK) 4/6 inhibitor, currently undergoing Phase 1b/2 trials for extensive-stage small cell lung cancer and Phase 2 trials for first-line small cell lung cancer and metastatic triple-negative breast cancer. The company is also developing lerociclib, an oral CDK4/6 inhibitor, which is in Phase 1b/2a trials for breast cancer and Phase 1b trials for non-small cell lung cancer. Additionally, G1 Therapeutics is progressing rintodestrant, an oral selective estrogen receptor degrader, currently in Phase I/2 trials. The company has partnered with Quantum Leap Healthcare Collaborative to evaluate trilaciclib for neoadjuvant treatment in locally advanced breast cancer. G1 Therapeutics aims to improve treatment outcomes for cancer patients through its innovative therapeutic approaches.
ORIG3N, Inc. is a biotechnology company focused on developing innovative treatments for rare genetically inherited diseases, particularly affecting the heart, liver, and neurodegenerative conditions. Founded in 2014 and based in Boston, Massachusetts, ORIG3N utilizes induced pluripotent stem cell technology, enabling the differentiation of cells into any type found in the body. This technology serves multiple purposes, including drug efficacy testing, medication toxicity screening, and facilitating personalized treatment approaches. The company's product offerings include LifeProfiles, a suite of genetic tests such as FITCODE, which provides insights into fitness-related traits; the Run DNA test for optimizing running performance; AURA, which assesses skin health; and Life Capsule, a repository for blood cells aimed at regenerative medicine development.
Lineagen, Inc. is a genetics diagnostic company based in Salt Lake City, Utah, specializing in genetic testing and clinical information services for neurodevelopmental disorders, particularly autism. Founded in 2002, the company offers a range of diagnostic tools, including FirstStepDx PLUS, a chromosomal microarray platform designed to identify genomic changes related to autism and other neurodevelopmental disorders, and NextStepDx PLUS, a genetic sequencing test for detecting small genomic alterations. Additionally, Lineagen provides M-CHAT.org, an online screening resource for developmental evaluation. The company focuses on improving outcomes for individuals with autism and other complex diseases by enabling early diagnosis and intervention. Lineagen's research capabilities are enhanced by its access to the Utah Population Database through the University of Utah, which supports significant discoveries in disease-related genetics. As of August 2020, Lineagen operates as a subsidiary of Bionano Genomics, Inc.
Clearside Biomedical, Inc. is a biopharmaceutical company focused on developing and commercializing innovative treatments for serious eye diseases. Founded in 2011 and based in Alpharetta, Georgia, the company utilizes a proprietary ocular microinjection platform to deliver therapies directly to specific compartments of the eye, including the retina and choroid. Its lead product, XIPERE, is a suprachoroidal injectable suspension of triamcinolone acetonide, targeting macular edema associated with conditions such as uveitis and diabetic macular edema. Additionally, Clearside is advancing CLS-AX, an axitinib formulation for suprachoroidal injection. The company's novel SCS Microinjector allows for a non-surgical, repeatable procedure aimed at preserving and restoring vision in patients with sight-threatening eye diseases.
MedCenterDisplay, LLC specializes in digital patient satisfaction and engagement solutions for hospitals and clinics across the United States. Founded in 2007 and based in Brentwood, Tennessee, the company offers a comprehensive range of services, including digital signage, online marketing, and application development, aimed at enhancing patient engagement and satisfaction. Their innovative digital signage systems are designed to effectively communicate with patients and their families while they wait for medical services. Additionally, MedCenterDisplay provides online marketing solutions such as search engine optimization, reputation management, social media support, and website development. The company's services are tailored to improve healthcare outcomes, reduce avoidable readmissions, and enhance patient experience metrics like HCAHPS. MedCenterDisplay operates as a subsidiary of PatientPoint, LLC, further solidifying its role in the healthcare marketing landscape.
Castle Biosciences, we focus on addressing this gap. We work with leading cancer institutions to in-license proprietary technologies and complete development and validation. The ultimate goal is to make these proven tests available to all individuals afflicted with a rare cancer.
InvisionHeart draws on the strengths of experienced leadership, robust software and hardware developers and a strong clinical advisory team. The technology was originally developed by a team of physicians and engineers at Vanderbilt University in response to real-world clinical problems. Along with their team of investors, they share a vision for the improved care of heart patients wherever they live and work.
NuSirt Sciences, Inc. is a biotechnology company based in Nashville, Tennessee, established in 2007. It focuses on developing innovative products for the prevention and treatment of metabolic diseases related to over-nutrition, such as obesity and type 2 diabetes. The company's technology platform combines natural compounds with pharmaceutical agents to activate sirtuin pathways, aiming to reduce the dosage of metformin, a standard treatment for early-stage type 2 diabetes, which some patients find difficult to tolerate due to side effects. NuSirt's lead product, NS-0100, combines leucine with a low dose of metformin and is currently undergoing Phase 2 clinical trials to determine its efficacy. The company has filed eleven patent applications, with two patents issued, and has conducted multiple pre-clinical and clinical studies to support its patented technologies. NuSirt has also formed strategic partnerships to enhance its research and development efforts in the field.
NuSirt Sciences, Inc. is a biotechnology company based in Nashville, Tennessee, established in 2007. It focuses on developing innovative products for the prevention and treatment of metabolic diseases related to over-nutrition, such as obesity and type 2 diabetes. The company's technology platform combines natural compounds with pharmaceutical agents to activate sirtuin pathways, aiming to reduce the dosage of metformin, a standard treatment for early-stage type 2 diabetes, which some patients find difficult to tolerate due to side effects. NuSirt's lead product, NS-0100, combines leucine with a low dose of metformin and is currently undergoing Phase 2 clinical trials to determine its efficacy. The company has filed eleven patent applications, with two patents issued, and has conducted multiple pre-clinical and clinical studies to support its patented technologies. NuSirt has also formed strategic partnerships to enhance its research and development efforts in the field.
Diagnovus, founded in 2011 and located in Nashville, TN, specializes in molecular diagnostics aimed at rare cancers, including pediatric forms. The company is committed to developing innovative diagnostic tests that enhance the decision-making process for physicians, patients, and families dealing with challenging health conditions. By focusing on evidence-based products, Diagnovus aims to improve patient outcomes, support healthcare providers in delivering more effective care, and promote the efficient use of healthcare resources. Through its dedication to improving health and treatment quality, Diagnovus seeks to make a significant impact in the field of molecular diagnostics.
G1 Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of small molecule therapeutics for cancer treatment. Founded in 2008, the company is headquartered in Research Triangle Park, North Carolina. G1 Therapeutics is advancing several investigational therapies, including trilaciclib, an intravenous cyclin-dependent kinase (CDK) 4/6 inhibitor, currently undergoing Phase 1b/2 trials for extensive-stage small cell lung cancer and Phase 2 trials for first-line small cell lung cancer and metastatic triple-negative breast cancer. The company is also developing lerociclib, an oral CDK4/6 inhibitor, which is in Phase 1b/2a trials for breast cancer and Phase 1b trials for non-small cell lung cancer. Additionally, G1 Therapeutics is progressing rintodestrant, an oral selective estrogen receptor degrader, currently in Phase I/2 trials. The company has partnered with Quantum Leap Healthcare Collaborative to evaluate trilaciclib for neoadjuvant treatment in locally advanced breast cancer. G1 Therapeutics aims to improve treatment outcomes for cancer patients through its innovative therapeutic approaches.
StreamWeaver is a software company based in Nashville, Tennessee, that specializes in developing innovative technology solutions. Its flagship product is a multi-angle mobile video application that allows users to connect and record videos together, automatically generating split-screen content. In addition to its video offerings, StreamWeaver provides a technology platform that facilitates the integration and streaming of data across various IT tools. This platform enables near real-time data connectivity with event-driven automation and comprehensive observability, aimed at reducing integration costs and enhancing productivity for clients.
ABT Molecular Imaging, based in Knoxville, Tennessee, specializes in medical imaging by designing, manufacturing, and marketing biomarker generator systems and related accessories. The company’s flagship product, the BG-75 Biomarker Generator, produces unit doses of molecular imaging drugs for positron emission tomography (PET) at the point of use, allowing for on-demand generation of PET biomarkers and radioisotopes. This innovative platform incorporates quality control tests and maintains dose records for each generated dose, ensuring high standards in medical imaging. Founded in 2006 by industry experts Ron and Lynda Nutt, ABT Molecular Imaging distributes its products through a global network of sales and service partners.
Diagnovus, founded in 2011 and located in Nashville, TN, specializes in molecular diagnostics aimed at rare cancers, including pediatric forms. The company is committed to developing innovative diagnostic tests that enhance the decision-making process for physicians, patients, and families dealing with challenging health conditions. By focusing on evidence-based products, Diagnovus aims to improve patient outcomes, support healthcare providers in delivering more effective care, and promote the efficient use of healthcare resources. Through its dedication to improving health and treatment quality, Diagnovus seeks to make a significant impact in the field of molecular diagnostics.
SwingPal is a proprietary online golf lesson platform that connects golfers and instructors over the web and via mobile devices. Users record their swings with a smart phone, upload their videos instantly to a SwingPal account, and receive detailed and annotated video and audio analysis from a golf pro, as well as additional instructional videos.
Diagnovus, founded in 2011 and located in Nashville, TN, specializes in molecular diagnostics aimed at rare cancers, including pediatric forms. The company is committed to developing innovative diagnostic tests that enhance the decision-making process for physicians, patients, and families dealing with challenging health conditions. By focusing on evidence-based products, Diagnovus aims to improve patient outcomes, support healthcare providers in delivering more effective care, and promote the efficient use of healthcare resources. Through its dedication to improving health and treatment quality, Diagnovus seeks to make a significant impact in the field of molecular diagnostics.
Pathfinder Technologies (formerly Pathfinder Therapeutics, Inc.), a medical device company, engages in the design, development, and manufacture of solutions in the field of navigated abdominal surgery. The company provides an integrated intra-operative image guidance system for open liver surgical procedure; and accessories, including IRED localization probes, navigated RF ablators, and navigated ultrasonic aspirators. Its system consists of a software architecture that allows the surgeon to display a 3D view of the liver. Its system is used in various open liver surgery applications, including hepatic resection, open ablation, open biopsy, living donor transplant, cyst removal, and tumor removal. Pathfinder Technologies was founded in 2004 and is based in Nashville, Tennessee.
Pathfinder Technologies (formerly Pathfinder Therapeutics, Inc.), a medical device company, engages in the design, development, and manufacture of solutions in the field of navigated abdominal surgery. The company provides an integrated intra-operative image guidance system for open liver surgical procedure; and accessories, including IRED localization probes, navigated RF ablators, and navigated ultrasonic aspirators. Its system consists of a software architecture that allows the surgeon to display a 3D view of the liver. Its system is used in various open liver surgery applications, including hepatic resection, open ablation, open biopsy, living donor transplant, cyst removal, and tumor removal. Pathfinder Technologies was founded in 2004 and is based in Nashville, Tennessee.
American Hometown Media, Inc. owns and operates an Internet platform to engage in analog publishing of American home cooks. The company syndicates the editorial content featuring journalism celebrating hometown cooks to community newspapers, magazines, and other media around the country. It also offers Just A Pinch Recipes, a digital recipe and coupon social network with a focus on home cooks; and Just A Pinch Syndicated Media, a platform to deliver content on home cooks, recipes, and snapshots of the culture and heritage of America's hometowns to media contacts. The company was founded in 2011 and is based in Nashville, Tennessee.
Diagnovus, founded in 2011 and located in Nashville, TN, specializes in molecular diagnostics aimed at rare cancers, including pediatric forms. The company is committed to developing innovative diagnostic tests that enhance the decision-making process for physicians, patients, and families dealing with challenging health conditions. By focusing on evidence-based products, Diagnovus aims to improve patient outcomes, support healthcare providers in delivering more effective care, and promote the efficient use of healthcare resources. Through its dedication to improving health and treatment quality, Diagnovus seeks to make a significant impact in the field of molecular diagnostics.
SwingPal is a proprietary online golf lesson platform that connects golfers and instructors over the web and via mobile devices. Users record their swings with a smart phone, upload their videos instantly to a SwingPal account, and receive detailed and annotated video and audio analysis from a golf pro, as well as additional instructional videos.
StreamWeaver is a software company based in Nashville, Tennessee, that specializes in developing innovative technology solutions. Its flagship product is a multi-angle mobile video application that allows users to connect and record videos together, automatically generating split-screen content. In addition to its video offerings, StreamWeaver provides a technology platform that facilitates the integration and streaming of data across various IT tools. This platform enables near real-time data connectivity with event-driven automation and comprehensive observability, aimed at reducing integration costs and enhancing productivity for clients.
ABT Molecular Imaging, based in Knoxville, Tennessee, specializes in medical imaging by designing, manufacturing, and marketing biomarker generator systems and related accessories. The company’s flagship product, the BG-75 Biomarker Generator, produces unit doses of molecular imaging drugs for positron emission tomography (PET) at the point of use, allowing for on-demand generation of PET biomarkers and radioisotopes. This innovative platform incorporates quality control tests and maintains dose records for each generated dose, ensuring high standards in medical imaging. Founded in 2006 by industry experts Ron and Lynda Nutt, ABT Molecular Imaging distributes its products through a global network of sales and service partners.
Diagnovus, founded in 2011 and located in Nashville, TN, specializes in molecular diagnostics aimed at rare cancers, including pediatric forms. The company is committed to developing innovative diagnostic tests that enhance the decision-making process for physicians, patients, and families dealing with challenging health conditions. By focusing on evidence-based products, Diagnovus aims to improve patient outcomes, support healthcare providers in delivering more effective care, and promote the efficient use of healthcare resources. Through its dedication to improving health and treatment quality, Diagnovus seeks to make a significant impact in the field of molecular diagnostics.
StreamWeaver is a software company based in Nashville, Tennessee, that specializes in developing innovative technology solutions. Its flagship product is a multi-angle mobile video application that allows users to connect and record videos together, automatically generating split-screen content. In addition to its video offerings, StreamWeaver provides a technology platform that facilitates the integration and streaming of data across various IT tools. This platform enables near real-time data connectivity with event-driven automation and comprehensive observability, aimed at reducing integration costs and enhancing productivity for clients.
SwingPal is a proprietary online golf lesson platform that connects golfers and instructors over the web and via mobile devices. Users record their swings with a smart phone, upload their videos instantly to a SwingPal account, and receive detailed and annotated video and audio analysis from a golf pro, as well as additional instructional videos.
Pathfinder Technologies (formerly Pathfinder Therapeutics, Inc.), a medical device company, engages in the design, development, and manufacture of solutions in the field of navigated abdominal surgery. The company provides an integrated intra-operative image guidance system for open liver surgical procedure; and accessories, including IRED localization probes, navigated RF ablators, and navigated ultrasonic aspirators. Its system consists of a software architecture that allows the surgeon to display a 3D view of the liver. Its system is used in various open liver surgery applications, including hepatic resection, open ablation, open biopsy, living donor transplant, cyst removal, and tumor removal. Pathfinder Technologies was founded in 2004 and is based in Nashville, Tennessee.
NuSirt Sciences, Inc. is a biotechnology company based in Nashville, Tennessee, established in 2007. It focuses on developing innovative products for the prevention and treatment of metabolic diseases related to over-nutrition, such as obesity and type 2 diabetes. The company's technology platform combines natural compounds with pharmaceutical agents to activate sirtuin pathways, aiming to reduce the dosage of metformin, a standard treatment for early-stage type 2 diabetes, which some patients find difficult to tolerate due to side effects. NuSirt's lead product, NS-0100, combines leucine with a low dose of metformin and is currently undergoing Phase 2 clinical trials to determine its efficacy. The company has filed eleven patent applications, with two patents issued, and has conducted multiple pre-clinical and clinical studies to support its patented technologies. NuSirt has also formed strategic partnerships to enhance its research and development efforts in the field.
MedCenterDisplay, LLC specializes in digital patient satisfaction and engagement solutions for hospitals and clinics across the United States. Founded in 2007 and based in Brentwood, Tennessee, the company offers a comprehensive range of services, including digital signage, online marketing, and application development, aimed at enhancing patient engagement and satisfaction. Their innovative digital signage systems are designed to effectively communicate with patients and their families while they wait for medical services. Additionally, MedCenterDisplay provides online marketing solutions such as search engine optimization, reputation management, social media support, and website development. The company's services are tailored to improve healthcare outcomes, reduce avoidable readmissions, and enhance patient experience metrics like HCAHPS. MedCenterDisplay operates as a subsidiary of PatientPoint, LLC, further solidifying its role in the healthcare marketing landscape.
Diabetes Care Group, Inc. provides diabetes clinical care services for individuals with diabetes. It offers medical management, patient education and personalized counseling, behavioral modification, diet and nutrition, specialized medical treatment, blood glucose monitoring, point-of-care laboratory, and data management services to improve patient self-management and clinical outcomes. Diabetes Care Group, Inc. was formerly known as Diabetes Care Associates, Inc. The company was founded in 1986 and is based in Jackson, Mississippi. Diabetes Care Group, Inc. operates as a subsidiary of Renal Care Group, Inc.
Pathfinder Technologies (formerly Pathfinder Therapeutics, Inc.), a medical device company, engages in the design, development, and manufacture of solutions in the field of navigated abdominal surgery. The company provides an integrated intra-operative image guidance system for open liver surgical procedure; and accessories, including IRED localization probes, navigated RF ablators, and navigated ultrasonic aspirators. Its system consists of a software architecture that allows the surgeon to display a 3D view of the liver. Its system is used in various open liver surgery applications, including hepatic resection, open ablation, open biopsy, living donor transplant, cyst removal, and tumor removal. Pathfinder Technologies was founded in 2004 and is based in Nashville, Tennessee.
OnFocus Healthcare, originally established in 1985 as a healthcare strategic planning consulting firm, transitioned in 2008 to focus on business execution software solutions. It specializes in providing enterprise performance management (EPM) software and support services tailored for the healthcare sector. Its flagship product, onFocus epm™, is designed to enhance patient care by enabling hospitals to improve their operational performance and execution capabilities. The software facilitates effective communication, management, and tracking of plans, metrics, and resources, promoting accountability within healthcare organizations. OnFocus Healthcare aims to boost the performance of its clients by at least 20%, supporting executives, managers, and employees in their efforts to deliver better, faster, and more cost-effective care.
Industrial Ceramic Solutions, LLC, based in Oak Ridge, Tennessee, specializes in the development and manufacture of air pollution control equipment, primarily focused on industrial and diesel exhaust filter applications. Founded in 1997 by Richard Nixdorf, who has over 40 years of experience in advanced materials, the company initially aimed to commercialize a microwave-regenerated diesel particulate filter (DPF) utilizing patented silicon carbide fibers. These fibers are designed to convert microwave energy into thermal energy rapidly, addressing the requirements set forth by the US Clean Air Act for diesel engine exhaust filtration. Although the microwave regeneration approach proved unfeasible, ICS successfully developed a ceramic fiber DPF cartridge that garnered significant interest from international automotive suppliers. In 2007, a Fortune 100 company secured an exclusive license to manufacture and sell this technology, although the agreement ended in 2008 due to a decline in the diesel engine market. Today, ICS continues to provide innovative solutions for diesel particulate and exhaust filtration, high-temperature exhaust, and air and gas treatment, while also addressing odor and smoke control needs.
Diagnovus, founded in 2011 and located in Nashville, TN, specializes in molecular diagnostics aimed at rare cancers, including pediatric forms. The company is committed to developing innovative diagnostic tests that enhance the decision-making process for physicians, patients, and families dealing with challenging health conditions. By focusing on evidence-based products, Diagnovus aims to improve patient outcomes, support healthcare providers in delivering more effective care, and promote the efficient use of healthcare resources. Through its dedication to improving health and treatment quality, Diagnovus seeks to make a significant impact in the field of molecular diagnostics.
Panopto, Inc. is a developer of a comprehensive video software platform aimed at the corporate and education sectors. Founded in 2007 and headquartered in Seattle, the company specializes in creating searchable video libraries that facilitate the management and dissemination of institutional knowledge. Its platform includes functionalities for video content management, live streaming, video analytics, and video recording, as well as tools for online editing and remote recording. Panopto's solutions support a range of applications, such as lecture capture, employee training, and live events, enhancing active learning and knowledge sharing. The company has received recognition for its innovation and rapid growth, with additional offices in locations including Pittsburgh, London, Sydney, and Hong Kong.
OnFocus Healthcare, originally established in 1985 as a healthcare strategic planning consulting firm, transitioned in 2008 to focus on business execution software solutions. It specializes in providing enterprise performance management (EPM) software and support services tailored for the healthcare sector. Its flagship product, onFocus epm™, is designed to enhance patient care by enabling hospitals to improve their operational performance and execution capabilities. The software facilitates effective communication, management, and tracking of plans, metrics, and resources, promoting accountability within healthcare organizations. OnFocus Healthcare aims to boost the performance of its clients by at least 20%, supporting executives, managers, and employees in their efforts to deliver better, faster, and more cost-effective care.